Folia Parasitologica 70:017 (2023) | DOI: 10.14411/fp.2023.017

Tetraspanins from the liver fluke Opisthorchis viverrini stimulate cholangiocyte migration and inflammatory cytokine production

Apisit Ruangsuwast1, Michael J. Smout ORCID...2, Paul J. Brindley ORCID...3, Alex Loukas ORCID...2, Thewarach Laha ORCID...1, Sujittra Chaiyadet ORCID...4, *
1 Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand;
2 Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia;
3 Department of Microbiology, Immunology and Tropical Medicine, and Research Center for Neglected Diseases of Poverty, School of Medicine & Health Sciences, George Washington University, Washington, D.C., USA;
4 Department of Tropical Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand *Address for correspondence: Sujittra Chaiyadet, Department of Tropical Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002 Thailand. E-mail: sujitch@kku.ac.th.

The liver fluke Opisthorchis viverrini (Poirier, 1886) (Digenea) secretes extracellular vesicles (EVs) bearing CD63-like tetraspanins on their surface. Fluke EVs are actively internalised by host cholangiocytes in the bile ducts, where they drive pathology and promote neoplasia through induction of cellular proliferation and secretion of inflammatory cytokines. We investigated the effects of tetraspanins of the CD63 superfamily by co-culturing recombinant forms of the large extracellular loop (LEL) of O. viverrini tetraspanin-2 (rLEL-Ov-TSP-2) and tetraspanin-3 (rLEL-Ov-TSP-3) with non-cancerous human bile duct (H69) and cholangiocarcinoma (CCA, M213) cell lines. The results showed that cell lines co-cultured with excretory/secretory products from adult O. viverrini (Ov-ES) underwent significantly increased cell proliferation at 48 hours but not 24 hours compared to untreated control cells (P < 0.05), whereas rLEL-Ov-TSP-3 co-culture resulted in significantly increased cell proliferation at both 24 hours (P < 0.05) and 48 hours (P < 0.01) time points. In like fashion, H69 cholangiocytes co-cultured with both Ov-ES and rLEL-Ov-TSP-3 underwent significantly elevated Il-6 and Il-8 gene expression for at least one of the time points assessed. Finally, both rLEL-Ov-TSP-2 and rLEL-Ov-TSP-3 significantly enhanced migration of both M213 and H69 cell lines. These findings indicated that O. viverrini CD63 family tetraspanins can promote a cancerous microenvironment by enhancing innate immune responses and migration of biliary epithelial cells.

Keywords: cholangiocarcinoma, host-parasite interaction, CD63-like tetraspanins, extracellular vesicle (EVs)

Received: May 16, 2023; Revised: July 7, 2023; Accepted: July 26, 2023; Published online: September 16, 2023  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Ruangsuwast, A., Smout, M.J., Brindley, P.J., Loukas, A., Laha, T., & Chaiyadet, S. (2023). Tetraspanins from the liver fluke Opisthorchis viverrini stimulate cholangiocyte migration and inflammatory cytokine production. Folia Parasitologica70, Article 2023.017. https://doi.org/10.14411/fp.2023.017
Download citation

Attachments

Download fileFP_070_017_17_Supp.pdf

File size: 318.67 kB

References

  1. Bassani S., Cingolani L.A. 2012: Tetraspanins: interactions and interplay with integrins. Int. J. Biochem. Cell Biol. 44: 703-708. Go to original source...
  2. Bi H., Zhang Y., Wang S., Fang W., He W., Yin L., Xue Y., Cheng Z., Yang M., Shen J. 2019: Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer. Oncol. Lett. 18: 4176-4184. Go to original source... Go to PubMed...
  3. Brindley P.J., Bachini M., Ilyas S.I., Khan S.A., Loukas A., Sirica A.E., Teh B.T., Wongkham S., Gores G.J. 2021: Cholangiocarcinoma. Nat. Rev. Dis. Primers 7: 65. Go to original source... Go to PubMed...
  4. Chaiyadet S., Krueajampa W., Hipkaeo W., Plosan Y., Piratae S., Sotillo J., Smout M., Sripa B., Brindley P.J., Loukas A., Laha T. 2017: Suppression of mRNAs encoding CD63 family tetraspanins from the carcinogenic liver fluke Opisthorchis viverrini results in distinct tegument phenotypes. Sci. Rep. 7: 14342. Go to original source... Go to PubMed...
  5. Chaiyadet S., Smout M., Johnson M., Whitchurch C., Turnbull L., Kaewkes S., Sotillo J., Loukas A., Sripa B. 2015a: Excretory/secretory products of the carcinogenic liver fluke are endocytosed by human cholangiocytes and drive cell proliferation and IL6 production. Int. J. Parasitol. 45: 773-781. Go to original source...
  6. Chaiyadet S., Sotillo J., Krueajampa W., Thongsen S., Brindley P.J., Sripa B., Loukas A., Laha T. 2019: Vaccination of hamsters with Opisthorchis viverrini extracellular vesicles and vesicle-derived recombinant tetraspanins induces antibodies that block vesicle uptake by cholangiocytes and reduce parasite burden after challenge infection. PLoS Negl. Trop. Dis. 13: e0007450. Go to original source...
  7. Chaiyadet S., Sotillo J., Krueajampa W., Thongsen S., Smout M., Brindley P.J., Laha T., Loukas A. 2022: Silencing of Opisthorchis viverrini tetraspanin gene expression results in reduced secretion of extracellular vesicles. Front. Cell Infect. Microbiol. 12: 827521. Go to original source... Go to PubMed...
  8. Chaiyadet S., Sotillo J., Smout M., Cantacessi C., Jones M.K., Johnson M.S., Turnbull L., Whitchurch C.B., Potriquet J., Laohaviroj M., Mulvenna J., Brindley P.J., Bethony J.M., Laha T., Sripa B., Loukas A. 2015b: Carcinogenic liver fluke secretes extracellular vesicles that promote cholangiocytes to adopt a tumorigenic phenotype. J. Infect. Dis. 212: 1636-1645. Go to original source...
  9. Hemler M.E. 2008: Targeting of tetraspanin proteins - potential benefits and strategies. Nat. Rev. Drug Discov. 7: 747-758. Go to original source... Go to PubMed...
  10. Hong I.K., Jeoung D.I., Ha K.S., Kim Y.M., Lee H. 2012: Tetraspanin CD151 stimulates adhesion-dependent activation of Ras, Rac, and Cdc42 by facilitating molecular association between beta1 integrins and small GTPases. J. Biol. Chem. 287: 32027-32039. Go to original source...
  11. IARC 2012: Biological agents. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyon, 499 pp.
  12. Levy S., Shoham T. 2005: The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5: 136-148. Go to original source... Go to PubMed...
  13. Marjon K.D., Termini C.M., Karlen K.L., Saito-Reis C., Soria C.E., Lidke K.A., Gillette J.M. 2016: Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin. Oncogene 35: 4132-4140. Go to original source... Go to PubMed...
  14. Ninlawan K., O'Hara S.P., Splinter P.L., Yongvanit P., Kaewkes S., Surapaitoon A., LaRusso N.F., Sripa B. 2010: Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte. Parasitol. Int. 59: 616-621. Go to original source... Go to PubMed...
  15. Ono M., Handa K., Withers D.A., Hakomori S. 2000: Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. Biochem. Biophys. Res. Commun. 279: 744-750. Go to original source...
  16. Phumrattanaprapin W., Chaiyadet S., Brindley P.J., Pearson M., Smout M.J., Loukas A., Laha T. 2021a: Orally administered Bacillus spores expressing an extracellular vesicle-derived tetraspanin protect hamsters against challenge infection with carcinogenic human liver fluke. J. Infect. Dis. 223: 1445-1455. Go to original source...
  17. Phumrattanaprapin W., Pearson M., Pickering D., Tedla B., Smout M., Chaiyadet S., Brindley P.J., Loukas A., Laha T. 2021b: Monoclonal antibodies targeting an Opisthorchis viverrini extracellular vesicle tetraspanin protect hamsters against challenge infection. Vaccines (Basel) 9: 740. Go to original source... Go to PubMed...
  18. Phung L.T., Chaiyadet S., Hongsrichan N., Sotillo J., Dieu H.D.T., Tran C.Q., Brindley P.J., Loukas A., Laha T. 2019: Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis. Parasitol. Res. 118: 3419-3427. Go to original source... Go to PubMed...
  19. Piratae S., Tesana S., Jones M.K., Brindley P.J., Loukas A., Lovas E., Eursitthichai V., Sripa B., Thanasuwan S., Laha T. 2012: Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini. PLoS Negl. Trop. Dis. 6: e1939. Go to original source...
  20. Schroder H.M., Hoffmann S.C., Hecker M., Korff T., Ludwig T. 2013: The tetraspanin network modulates MT1-MMP cell surface trafficking. Int. J. Biochem. Cell. Biol. 45: 1133-1144. Go to original source...
  21. Seubert B., Cui H., Simonavicius N., Honert K., Schafer S., Reuning U., Heikenwalder M., Mari B., Kruger A. 2015: Tetraspanin CD63 acts as a pro-metastatic factor via beta-catenin stabilization. Int. J. Cancer 136: 2304-2315. Go to original source...
  22. Smout M.J., Sotillo J., Laha T., Papatpremsiri A., Rinaldi G., Pimenta R.N., Chan L.Y., Johnson M.S., Turnbull L., Whitchurch C.B., Giacomin P.R., Moran C.S., Golledge J., Daly N., Sripa B., Mulvenna J.P., Brindley P.J., Loukas A. 2015: Carcinogenic parasite secretes growth factor that accelerates wound healing and potentially promotes neoplasia. PLoS Pathog. 11: e1005209. Go to original source... Go to PubMed...
  23. Sripa B., Brindley P.J., Mulvenna J., Laha T., Smout M.J., Mairiang E., Bethony J.M., Loukas A. 2012: The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol. 28: 395-407. Go to original source... Go to PubMed...
  24. Sripa B., Kaewkes S. 2000: Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. Int. J. Parasitol. 30: 735-740. Go to original source...
  25. Sripa B., Kaewkes S., Sithithaworn P., Mairiang E., Laha T., Smout M., Pairojkul C., Bhudhisawasdi V., Tesana S., Thinkamrop B., Bethony J.M., Loukas A., BrindleyP.J. 2007: Liver fluke induces cholangiocarcinoma. PLoS Med. 4: e201. Go to original source... Go to PubMed...
  26. Sripa B., Seubwai W., Vaeteewoottacharn K., Sawanyawisuth K., Silsirivanit A., Kaewkong W., Muisuk K., Dana P., Phoomak C., Lert-Itthiporn W., Luvira V., Pairojkul C., Teh B.T., Wongkham S., Okada S., Chamgramol Y. 2020: Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Hum. Cell. 33: 695-708. Go to original source... Go to PubMed...
  27. Surapaitoon A., Suttiprapa S., Khuntikeo N., Pairojkul C., Sripa B. 2017: Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients. Parasitol. Int. 66: 889-892. Go to original source... Go to PubMed...
  28. Syal G., Fausther M., Dranoff J.A. 2012: Advances in cholangiocyte immunobiology. Am. J. Physiol. Gastrointest. Liver Physiol. 303: G1077-1086. Go to original source... Go to PubMed...
  29. Techasen A., Loilome W., Namwat N., Khuntikeo N., Puapairoj A., Jearanaikoon P., Saya H., Yongvanit P. 2014: Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. Tumour Biol. 35: 8645-8652. Go to original source...
  30. Wang H., Zhang W., Zhao J., Zhang L., Liu M., Yan G., Yao J., Yu H., Yang P. 2012: N-Glycosylation pattern of recombinant human CD82 (KAI1), a tumor-associated membrane protein. J. Proteomics 75: 1375-1385. Go to original source... Go to PubMed...
  31. Wilson R.A., Jones M.K. 2021: Fifty years of the schistosome tegument: discoveries, controversies, and outstanding questions. Int. J. Parasitol. 51: 1213-1232. Go to original source...
  32. Yoshida T., Ebina H., Koyanagi Y. 2009: N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Microbiol. Immunol. 53: 629-635. Go to original source... Go to PubMed...